The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: dexamethasone     Quarter: 2016Q3

Total Records: 1,559     Number of Pages: 78

DRUGNAME PT EventCount
DEXAMETHASONE. Cognitive disorder 12
DEXAMETHASONE. Gastrointestinal disorder 12
DEXAMETHASONE. Hypersensitivity 12
DEXAMETHASONE. Leukopenia 12
DEXAMETHASONE. Malignant neoplasm progression 12
DEXAMETHASONE. Nasopharyngitis 12
DEXAMETHASONE. Pruritus 12
DEXAMETHASONE. Respiratory tract infection viral 12
DEXAMETHASONE. Skin discolouration 12
DEXAMETHASONE. Synovial cyst 12
DEXAMETHASONE. Tearfulness 12
DEXAMETHASONE. Weight decreased 12
DEXAMETHASONE. Basal cell carcinoma 11
DEXAMETHASONE. Blood lactate dehydrogenase increased 11
DEXAMETHASONE. Drug resistance 11
DEXAMETHASONE. Ear discomfort 11
DEXAMETHASONE. Electrocardiogram QT prolonged 11
DEXAMETHASONE. General physical health deterioration 11
DEXAMETHASONE. Hyperhidrosis 11
DEXAMETHASONE. Infusion site erythema 11

Total Records: 1,559     Number of Pages: 78